UBX NASDAQ
Unity Biotechnology, Inc.
1W: -43.8%
1M: -79.5%
3M: -94.6%
1Y: -96.1%
3Y: -99.1%
5Y: -99.9%
$0.20
Last traded 2025-08-04 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
-$867K
+95.6% ▲
Operating Income
-$31M
+30.2% ▲
Net Income
-$26M
+34.8% ▲
EPS (Diluted)
$-1.54
+43.0% ▲
EBITDA
-$25M
+32.6% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $0 | $5M | $236K | $0 | $0 |
| YoY Growth | +0.0% | +0.0% | -95.1% | -100.0% | +0.0% |
| Cost of Revenue | $3M | $3M | $2M | $20M | $867K |
| Gross Profit | -$3M | $2M | -$2M | -$20M | -$867K |
| Gross Margin | — | 39.8% | -823.7% | — | — |
| R&D Expenses | $67M | $38M | $37M | $21M | $13M |
| SG&A Expenses | $24M | $23M | $21M | $19M | $15M |
| Operating Expenses | $88M | $59M | $22M | $25M | $28M |
| Operating Income | -$91M | -$57M | -$58M | -$45M | -$31M |
| Operating Margin | — | -1184.5% | -24394.9% | — | — |
| Interest Expense | $1M | $3M | $4M | $0 | $0 |
| Income Before Tax | -$94M | -$61M | -$44M | -$40M | -$26M |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$94M | -$61M | -$44M | -$40M | -$26M |
| Net Margin | — | -1269.3% | -18842.8% | — | — |
| EPS (Diluted) | $-18.45 | $-10.90 | $-4.68 | $-2.70 | $-1.54 |
| EBITDA | -$89M | -$55M | -$39M | -$37M | -$25M |
| Shares Outstanding | 5M | 6M | 9M | 15M | 17M |